Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.681 USD | +7.24% | +6.41% | +21.61% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.61% | 68.31M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board